Hormone silent giant adrenal incidentaloma-adrenal ganglioneuroma: case report and literature review

Introduction

Ganglioneuromas (GNs) are rare, benign, well-differentiated neurogenic tumors that arise from neural crest cells. GNs usually occur along the paravertebral sympathetic ganglia [1], possible locations include from the skull base to the pelvis, the posterior mediastinum, the neck, or in the retroperitoneum [2]. Adrenal GNs are less common (21 % of all GNs) [3]. AGNs are considered “giant” when the diameter of the adrenal tumor is > 6 cm. The preoperative diagnosis of an adrenal tumor is critically important to avoid some devastating perioperative complications, such as a hypertensive crisis, severe hypotension, and/or adrenal crisis. Once we get a preliminary judgment of the tumor’s endocrine characteristics, surgery is often considered. Giant tumors always pose a certain challenge to surgeons considering the appropriate procedure approach (laparoscopic vs. open surgery).

Publication History

Article published online:
17 June 2021

• References

• 1 Lonergan GJ, Schwab CM, Suarez ES. et al. From the archives of the AFIP: neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 2002; 22: 911-934
• 2 Enzinger F. Primitive neuroectodermal tumors and related lesions. Soft tissue tumors 2001; 1289-1321
• 3 Lee JH, Chai YJ, Kim TH. et al. Clinicopathological Features of Ganglioneuroma Originating From the Adrenal Glands. World J Surg 2016; 40: 2970-2975
• 4 Sarwal A, Khullar R, Sharma A. et al. Laparoscopic adrenalectomy for ganglioneuroma presenting as an adrenal incidentaloma. Journal of minimal access surgery 2019; 15: 259
• 5 Nokes BT, Baumann CP, Cummings KW. et al. Intrathoracic ganglioneuroma presenting as an endobronchial mass. Respiratory medicine case reports 2017; 22: 209-211
• 6 Mora J, Gerald WL. Origin of neuroblastic tumors: clues for future therapeutics. Expert Review of Molecular Diagnostics 2004; 4: 293-302
• 7 Mantero F, Terzolo M, Arnaldi G. et al. A survey on adrenal incidentaloma in Italy. The Journal of Clinical Endocrinology & Metabolism 2000; 85: 637-644
• 8 Nardi WS, Quildrian SD. Left adrenal ganglioneuroma: Report of a new case. International journal of surgery case reports 2018; 45: 143-145
• 9 Radin R, David CL, Goldfarb H. et al. Adrenal and extra-adrenal retroperitoneal ganglioneuroma: imaging findings in 13 adults. Radiology 1997; 202: 703-707
• 10 Kumar S, Singh S, Chandna A. Organ preservation in a case of retroperitoneal ganglioneuroma: a case report and review of literature. Case Reports in Surgery 2016; DOI: 10.1155/2016/6597374.
• 11 Cai J, Zeng Y, Zheng H. et al. Retroperitoneal ganglioneuroma in children: CT and MRI features with histologic correlation. European journal of radiology 2010; 75: 315-320
• 12 d’Amuri FV, Maestroni U, Pagnini F. et al. Magnetic resonance imaging of adrenal gland: state of the art. Gland Surgery 2019; 8: S223
• 13 Wang F, Liu J, Zhang R. et al. CT and MRI of adrenal gland pathologies. Quant Imaging Med Surg 2018; 8: 853-875
• 14 Yao ZG, Liu XM, Qin YJ. Spontaneous Maturation of Neuroblastoma to Ganglioneuroma: Two Case Studies. Fetal Pediatr Pathol 2016; 35: 410-415
• 15 Gassenmaier S, Tsiflikas I, Fuchs J. et al. Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors. Cancer Imaging 2020; 20: 89
• 16 Neubauer H, Li M, Müller V. et al. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2017; 189: 640-650